Table 2.

Median scores and diagnostic performance of ELF and TE according to METAVIR fibrosis stage

	ELF score (n = 182)			TE (kPa) (n = 182)
Fibrosis stage	Median (IQR)	AUROC (95% CI)	Adjusted AUROC	Median (IQR)	AUROC (95% CI)	Adjusted AUROC	P value*
0 vs 1–4	8.21 (1.08) vs 9.39 (1.81)	0.77 (0.67–0.87)	0.81	5.55 (2.08) vs 8.50 (5.93)	0.86 (0.78–0.94)	0.90	0.09
0,1 vs 2–4	8.35 (1.13) vs 9.82 (1.53)	0.82 (0.76–0.88)	0.86	6.30 (2.47) vs 9.80 (6.43)	0.86 (0.80–0.91)	0.89	0.34
0–2 vs 3,4	8.75 (1.35) vs 10.06 (1.83)	0.80 (0.73–0.87)	0.83	6.90 (2.60) vs 13.00 (11.10)	0.90 (0.85–0.95)	0.94	<0.01
0–3 vs 4	9.01 (1.61) vs 10.60 (2.16)	0.83 (0.76–0.90)	0.86	7.60 (2.93) vs 16.15 (14.77)	0.95 (0.91–0.98)	0.96	<0.01

IQR, interquartile range; AUROC, area under receiver operator characteristic curve; CI, confidence interval.

^*Significance of comparison of observed ELF and TE AUROC values.